Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL169726 | 0.79 | ALDH1A1 (0.39) | TSHRALDH1A1THRB | |
| SCHEMBL9514502 | 0.77 | ALDH1A1 (0.38) | TSHRALDH1A1 | |
| SCHEMBL16767715 | 0.77 | ALDH1A1 (0.38) | TSHRALDH1A1 | |
| SCHEMBL28104274 | 0.73 | TSHR (0.39) | TSHRALDH1A1THRB | |
| SCHEMBL9048760 | 0.72 | MEN1 (0.35) | TSHRALDH1A1 | |
| SCHEMBL27385530 | 0.71 | ALDH1A1 (0.44) | TSHRALDH1A1THRB | |
| SCHEMBL809303 | 0.70 | ALDH1A1 (0.40) | TSHRALDH1A1THRB | |
| Bicarbonate SCHEMBL27518089 | 0.70 | TSHR (0.37) | TSHRALDH1A1THRB | |
| SCHEMBL18427851 | 0.70 | THRB (0.39) | TSHRALDH1A1THRB | |
| SCHEMBL3846902 | 0.70 | ALDH1A1 (0.32) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240002581-A1 | SEMICARBAZIDE COMPOSITION AND WATER-BASED COATING COMPOSITION | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-01-04 | — | — | US | disclosed |
| EP-4245751-A1 | SEMICARBAZIDE COMPOSITION AND AQUEOUS COATING COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2023-09-20 | — | — | EP | disclosed |
| US-20220010163-A1 | SEMICARBAZIDE COMPOSITION, WATER-BASED COATING COMPOSITION, COATING FILM, ARTICLE, AND METHOD FOR PRODUCING SEMICARBAZIDE COMPOSITION | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2022-01-13 | — | — | US | disclosed |
| EP-3889223-A1 | SEMICARBAZIDE COMPOSITION, WATER-BASED COATING COMPOSITION, COATING FILM, ARTICLE, AND METHOD FOR PRODUCING SEMICARBAZIDE COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2021-10-06 | — | — | EP | disclosed |
| US-7175892-B2 | Emulsion and coating liquid and recording medium using the same | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2007-02-13 | — | — | US | disclosed |
| EP-1626060-A1 | Monomeric composition, copolymers obtainable therefrom and aqueous dispersions containing them | Celanese Emulsions Iberica, S.L. (ES) | 2006-02-15 | — | — | EP | disclosed |
| US-20060020079-A1 | Monomeric composition, copolymers obtainable therefrom and aqueous dispersions containing them | CELANESE EMULSIONS IBERICA, S.L. | 2006-01-26 | — | — | US | disclosed |
| US-20040115370-A1 | Emulsion and coating liquid and recording medium using the same | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1380438-A1 | EMULSION AND COATING LIQUID AND RECORDING MEDIUM USING THE SAME | Asahi Kasei Kabushiki Kaisha (JP) | 2004-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002581-A1 | SEMICARBAZIDE COMPOSITION AND WATER-BASED COATING COMPOSITION | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDAC1, H1-0 | TSHR 4198/4885ALDH1A1 276/4885THRB 2866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.